Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109063) titled 'Non-Comedogenic Effect of Boreum UVBeat Hydrating and Barrier Protecting Sunscreen SPF 50 PA 4plus (SF109)' on April 22.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Boreum Private Limited
Intervention:
Intervention1: Test product: UVBeat Hydrating & Barrier Protecting Sunscreen SPF 50 PA++++ (SF109): Take sufficient amount of test product Apply in outword direction once a day, Route of Administration: Topical, Duration: 28days
Control Interventi...